Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
2012
World Health Organization‐defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management
2014
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP)
2009
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial
2004
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
2010
Early Detection of Toxoplasma Infection by Molecular Monitoring of Toxoplasma gondii in Peripheral Blood Samples after Allogeneic Stem Cell Transplantation
2004
Diagnosis ofToxoplasma gondiiinfection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny
2010
Acute graft-vs-host disease
2001
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
2005
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease
2006
Chronic graft-versus-host disease
2003 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial
2016
Graft-versus-host disease
2009 Standout
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
2004
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation
2005
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
2004
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
2011
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Immunity to fungal infections
2011 Standout
IgE, mast cells, basophils, and eosinophils
2010 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
2005
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
2003
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of M. Bischoff being referenced
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study
2001
S2e guideline: positioning and early mobilisation in prophylaxis or therapy of pulmonary disorders
2015
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients
1998
Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation
1998
Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant
2000
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient
1998
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA‐mismatched bone marrow transplant patients
2000
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience
2001
Oral dolasetron mesilate (MDL 73,147EF) for the control of emesis during fractionated total-body irradiation and high-dose cyclophosphamide in patients undergoing allogeneic bone marrow transplantation
1997
Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience
2001